BPG is committed to discovery and dissemination of knowledge
- Number of total visits
-
2737629
- Number of visits today
- 909
- Number of downloads
-
2008993
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Coşkun GP, Sahin Z, Erdoğan Ö, Çevik Ö, Biltekin SN, Yurttas L, Berk B, Ülgen M, Demirayak Ş. Discovery of novel potent human chondrosarcoma (SW1353) inhibitors: 4-(2/3/4-pyridyl)thiazole 2-acetamide derivatives. Journal of Molecular Structure 2023;1273:134260. [DOI: 10.1016/j.molstruc.2022.134260] [Reference Citation Analysis]
|
2 |
Bhattacharya S, Sharma S, Prajapati BG. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.990841] [Reference Citation Analysis]
|
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345